Menninger v. PPD Development, L.P.

CourtCourt of Appeals for the First Circuit
DecidedJuly 24, 2025
Docket23-2030
StatusPublished

This text of Menninger v. PPD Development, L.P. (Menninger v. PPD Development, L.P.) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Menninger v. PPD Development, L.P., (1st Cir. 2025).

Opinion

United States Court of Appeals For the First Circuit No. 23-2030

LISA MENNINGER,

Plaintiff, Appellee,

v.

PPD DEVELOPMENT, L.P.,

Defendant, Appellant.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS

[Hon. Leo T. Sorokin, U.S. District Judge]

Before

Aframe and Kayatta,* Circuit Judges.

Douglas Hallward-Driemeier, with whom John P. Bueker and Ropes & Gray LLP were on brief, for appellant. Stephanie Schuster, Douglas W. Baruch, Jennifer M. Wollenberg, and Morgan, Lewis & Bockius LLP on brief for National Association of Manufacturers, amicus curiae. Patrick J. Hannon, with whom Hartley Michon Robb Hannon LLP was on brief, for appellee.

July 24, 2025

* Judge Selya heard oral argument in this case and participated in the initial semble thereafter. His death on February 22, 2025, ended his involvement in this case. The remaining two panelists issued this opinion pursuant to 28 U.S.C. § 46(d). KAYATTA, Circuit Judge. Dr. Lisa Menninger was the

Executive Director for Laboratory Operations at a clinical

laboratory division of PPD Development, L.P. (PPD). Menninger

claims that PPD discriminated and retaliated against her because

of her social anxiety disorder, in violation of the Americans with

Disabilities Act (ADA) and Massachusetts antidiscrimination law.

A jury agreed and awarded Menninger more than twenty-four million

dollars in damages. PPD then moved for judgment as a matter of

law, a new trial, and remittitur, but the district court denied

those motions. For the reasons detailed below, we affirm.

I.

A.

Because PPD challenges the sufficiency of the evidence

supporting the jury's verdict, we recount the events in the light

most favorable to Menninger, "drawing all factual inferences and

resolving all credibility determinations in her favor." Dimanche

v. Mass. Bay Transp. Auth., 893 F.3d 1, 4 n.2 (1st Cir. 2018); see

also Franchina v. City of Providence, 881 F.3d 32, 38 (1st Cir.

2018) ("[O]ur recounting of the facts . . . defer[s] to the jury's

discernible resolution of disputed factual issues." (quotation

marks and citation omitted)).

B.

PPD is a clinical research organization. It assists

pharmaceutical companies in testing new drugs, researching

- 2 - vaccines, and organizing and analyzing data from clinical trials.

One of its divisions, Global Central Labs, focuses on clinical

laboratory testing. Menninger was its Executive Director for

Laboratory Operations.

In 2017, its business stagnating, PPD's senior

management decided to implement a plan focusing on client

relationships. As part of that plan, PPD tasked its operational

leads -- including Menninger -- with increasing their involvement

in client pitches, bid defenses, and other engagements with

clients.

When Menninger's supervisor, Hacene Mekerri, told her

about the planned change in her duties, Menninger balked. She

explained to Mekerri that public presentations in front of large

crowds "ma[d]e [her] anxious." Mekerri "tried to reassure [her]"

that she was capable of the public speaking he had in mind, and he

suggested that they return to the discussion "after the holidays."

On January 11, 2018, Menninger emailed Mekerri to continue the

conversation. She informed him that she suffered from generalized

anxiety disorder, social anxiety disorder, and panic attacks,

which she treated with medication as needed. She also explained

that increased client visits, social interactions, and

presentations would be "difficult in light of [her] disability,"

and that she was "open to discussing whatever ideas" Mekerri had

for her role.

- 3 - PPD proposed that Menninger have her doctor recommend

accommodations that might allow Menninger to perform her new

duties. After consulting with an attorney and her doctor, she

agreed.

On January 31, 2018, Menninger's psychiatrist,

Dr. Marianna Kessimian, submitted a written accommodation request

on Menninger's behalf. The request noted that Menninger could

"tolerate" public speaking and social interaction "to the extent

that they [were] necessary for her job." However, it cautioned

that expanding Menninger's public-speaking and social-interaction

responsibilities would "increase her anxiety and worsen her

somatic symptoms," making it "substantially more difficult, if not

impossible, for [Menninger] to perform her job." Kessimian

suggested three possible accommodations: (1) minimizing social

interaction or public speaking "to the extent possible"; (2) not

changing Menninger's role to require more public speaking or social

interactions; and (3) developing a "plan" for any necessary public

speaking and social interactions, in consultation with Kessimian

or another qualified healthcare provider, so as to "minimize

[Menninger's] anxiety and somatic symptoms."

In response, Human Resources (HR) Associate Director

Chad St. John asked Menninger for additional information from her

physician regarding the specific duties Mekerri had raised that

Menninger could not perform. St. John also prompted Mekerri to

- 4 - send Menninger an email, on February 6, listing five broad

categories of public-speaking and social tasks that Menninger

would be expected to perform (specifying the frequency and number

of attendees for some, but not all, of the tasks). Some of the

listed activities were ones that Menninger performed "regularly

without issue," whereas others -- like being physically present

for client site visits -- marked a sharp departure from her

previous role.

Menninger worked with Kessimian to request a second set

of accommodations specifically tailored to Mekerri's emailed list.

Kessimian's additional suggestions included providing a "surrogate

or reader" to attend client meetings or make presentations on

Menninger's behalf. Kessimian also said that Menninger was "able

to build business relationship[s] in a more 'behind the scenes'

fashion and would like [to] brainstorm other potential avenues

where she [could] add value" in the business-development context.

Kessimian submitted the request on February 14, 2018.

St. John responded by email to Menninger twelve days

later, stating that PPD could accommodate Menninger's requests for

a surrogate to present at internal meetings, as well as her request

to reduce travel expectations. However, he indicated that PPD

could not make any accommodations with regard to "Client Bid

Defense," "Issue resolution calls," "HH/Client site meetings,"

- 5 - "phone," "Technical Sales presentation internal and external," and

"Lunch/dinner and social interactions" during customer visits.

Two days later, Menninger was scheduled to meet with

St. John and Mekerri to discuss the accommodation requests. Before

the meeting, St. John emailed Deborah Ballweg, HR Executive

Director, and mentioned "delicately working [Menninger] out,"

explaining that he and Mekerri "[g]ave only slightly on two out of

five items that her physician requested" as reasonable

accommodations.

During the meeting with St. John and Mekerri, Menninger

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Pacific Mutual Life Insurance v. Haslip
499 U.S. 1 (Supreme Court, 1991)
Kolstad v. American Dental Assn.
527 U.S. 526 (Supreme Court, 1999)
Barnes v. Gorman
536 U.S. 181 (Supreme Court, 2002)
Unitherm Food Systems, Inc. v. Swift-Eckrich, Inc.
546 U.S. 394 (Supreme Court, 2006)
Correa v. Hospital San Francisco
69 F.3d 1184 (First Circuit, 1995)
Kvorjak v. Maine, State of
259 F.3d 48 (First Circuit, 2001)
Blockel v. J.C. Penney Company
337 F.3d 17 (First Circuit, 2003)
Richards v. Relentless, Inc.
341 F.3d 35 (First Circuit, 2003)
Connelly v. Hyundai Motor Co.
351 F.3d 535 (First Circuit, 2003)
Zachar v. Lee
363 F.3d 70 (First Circuit, 2004)
Flynn v. AK Peters, Ltd.
377 F.3d 13 (First Circuit, 2004)
United States v. Maldonado-Garcia
446 F.3d 227 (First Circuit, 2006)
Mulloy v. Acushnet Company
460 F.3d 141 (First Circuit, 2006)
Casillas-Diaz v. Palau
463 F.3d 77 (First Circuit, 2006)
Tobin v. Liberty Mutual Insurance
553 F.3d 121 (First Circuit, 2009)
Mendez-Matos v. Municipality of Guaynabo
557 F.3d 36 (First Circuit, 2009)
Costa-Urena v. Segarra
590 F.3d 18 (First Circuit, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
Menninger v. PPD Development, L.P., Counsel Stack Legal Research, https://law.counselstack.com/opinion/menninger-v-ppd-development-lp-ca1-2025.